• Español
  • English
  • facebook
  • twitter
  • rss
  • Español
  • English
  • facebook
  • twitter
  • rss
TNI D&D
  • Home
  • About us
    • About us
    • People
    • Partners
    • Researchers
    • Contact us
    • In the media
    • Newsletter
  • Newsroom
    • Press contacts
    • Press releases
    • Resources
    • Drugs in the news
  • Issues
    • Drug policy debate in the Americas
    • Decriminalization
    • Proportionality of sentences
    • Harm reduction
    • Reclassification of substances
    • Safer crack use
    • Human rights
    • Regulation
    • Unscheduling the coca leaf
    • Ending the war on drugs
    • Alternative development
    • Cannabis
    • Producers of Crops
    • Law enforcement
    • ATS, Mild stimulants & NPS
    • European Drug Policy
    • Money Laundering
  • UN Drug
    Control
    • Conventions
    • UNODC
    • CND
    • INCB
    • UNGASS
  • Country
    information
    • Drug Law Reform on the Map
    • Central America
      • El Salvador
      • Guatemala
      • Honduras
      • Costa Rica
    • Latin America
      • Argentina
      • Bolivia
      • Paraguay
      • Brazil
      • Chile
      • Colombia
      • Ecuador
      • Peru
      • Uruguay
      • Venezuela
    • Mexico
    • Caribbean
      • Jamaica
      • Belize
    • Afghanistan
  • Events
    • Expert Seminars
    • Informal Policy Dialogues
    • Public Events
    • Judges for Law Reform
  • Publications
    • Drug Policy Briefings
    • Drug Law Reform
    • Legislative Reform Series
    • The Human Face
    • Drugs & conflict
    • Drugs and the Law (CEDD)
      • Systems overload
    • Drug Markets and Violence
  • Weblog

 

Summary of report Beckley Foundation

‘Licensing and Regulation of the Cannabis Market in England and Wales: Towards A Cost Benefit Analysis’

The Beckley report, Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost-Benefit Analysis, grasps of the economic consequences of a regulated market, as opposed to the current prohibitionist model. This is essential for evaluating the impacts of possible drug policy reform. The report outlines the factors which must be included in further cost-benefit analyses. The report costed 60.000 pounds and 3 years to create. Reliable data was often lacking and more evidence is needed.

One of the key advantages to a cost-benefit analysis is its complete elimination of subjective and emotive processes, which have become an unfortunate mainstay in the drug policy debate - this gives the results an objective credibility.

It is very important to note that by excluding 'internal costs and benefits' the report specifically excludes the reasons why people use cannabis, such as medication, enjoyment and creativity - instead this report takes the perspective of a concerned tax payer, or a budget-focused politician.

An often-used argument surrounding cannabis reform is the concept of the 'gateway effect'; the idea that cannabis use leads to the use of 'harder drugs'. This report not only rejects the idea of a demand side gateway effect (through a thorough assessment of the available data), but also introduces the idea that a regulated market would virtually eliminate another sort of damaging gateway effect, namely the supply-side gateway. This is where social dealers of cannabis come into contact with professional dealers of a larger variety of drugs and thus are more likely to progress to dealing harder drugs.

Another element which has gained much attention in recent history is the mental health costs of cannabis brought about by the increased ratio of THC to CBD. One of the many advantages of a regulated market is that through health-education, labelling and variable tax rates, strains of cannabis with a high CBD ratio can be encouraged, particularly for vulnerable users.

The main conclusion is that there would be a net social benefit to reform of some­where between 280 and 460 million pounds. This means that even when we ignore the experiential benefits claimed by cannabis users and just focus on the financial effects on society at large, the argument for reform remains robust, compelling and increasingly difficult for policy makers to ignore.

On top of the financial benefit there are of course many other advantages. These include increased respect of human rights, the avoidance of discrimination in the enforcement of prohibition, the minimisation of the blighting effect of a criminal record on a person’s life and the increased accessibility to health information and treatment. The current criminalization of cannabis users sacrifices the credibility of health campaigns. Moreover, based on US evidence it is expected that access to cannabis for teenagers would probably decrease.

Because taxes are a transfer, rather than a net social gain, they are not included in the report’s cost benefit analysis. However, a conservative estimation is made of what the tax revenue might be following reform.

The authors aim to bring the price of cannabis to lower than the illicit price, whilst aiming to keep it high enough to deter the expansion of use due to low price, particularly by the young. This would be achieved by a tax rate of around 70%, which is lower than the 83% on cigarettes and closer to the 72% on high alcohol beer.

The report predicts a small increase in cannabis quantity [+15% - +40%] due to a decreased cannabis price. The price elasticity of cannabis is estimated between [-0.2, -0.7]. The cross-price elasticity is important to consider: will alcohol consumption decrease if the price of cannabis decreases and cannabis consumption increases? According to a study of Clements and Zhao (2005), a4% increase in cannabis consumption would lead to a decrease of alcohol consumption (-1% beer, -2% wine, -4% spirits).

The authors assumed a cap on THC levels of 10% for licensed cannabis. By creating this limitation it leaves higher THC strains of cannabis in the illicit market. It would probably be better to keep all strains of cannabis within the licit market, and use taxation intelligently to make more potentially risky or harmful strains of cannabis less financially attractive. Campaigns could move users away from combining tobacco and cannabis.

The authors estimate that the government would gain in budgetary terms by something around one billion pounds a year, roughly three quarters of which would come from tax revenues rather than expenditure savings. In these times of economic hardship cost-benefit analyses with positive results should surely begin to play a key role in government.

The report

Mark Bryan, Emilia Del Bono, Stephen Pudney, Licensing and Regulation of the Cannabis Market in England and Wales: Towards a Cost-Benefit Analysis, Institute for Social and Economic Research (Iser), University of Essex & Beckley Foundation, September 2013

  • Labels
    teen use | gateway theory | UK | regulation | cannabis

Drugs in the News

  • Cannabis cafés and self-growing: Czechia presents draft of new marijuana law
    11.01.2024
  • Minister signs bill banning recreational use of weed
    08.01.2024
  • As the mayor of Amsterdam, I can see the Netherlands risks becoming a narco-state
    05.01.2024
  • Barcelona city council threatens to shut down cannabis social clubs
    04.01.2024
  • Swiss capital Bern considers legal cocaine project
    20.12.2023
  • High time: after five years, Dutch start legal cannabis trial
    15.12.2023
More news

Weblog

    Willful blindness: INCB can find nothing good to say on cannabis legalisation
    14.03.2023
More weblog

Hilites

Balancing Treaty Stability and Change

balancing hilite

Inter se modification of the UN drug control conventions to facilitate cannabis regulation


Connecting the dots...

connecting dots hilite

Human rights, illicit cultivation and alternative development


Morocco and Cannabis

morocco cannabis hilite

Reduction, containment or acceptance


The Rise and Decline of Cannabis Prohibition

rise decline hilite

The History of Cannabis in the UN Drug Control System and Options For Reform


Tags

10-year Review  20 1998 UNGASS  26 2005 CND debate  8 2016 UNGASS  126 2019 HLM  5 activism  38 afghanistan  25 show all

Tags

10-year Review  20 1998 UNGASS  26 2005 CND debate  8 2016 UNGASS  126 2019 HLM  5 activism  38 afghanistan  25 hide
africa  14 albania  14 alternative development  120 alternatives to policing  2 amnesty  89 amphetamine  1 amsterdam  30 appellation of origin  3 argentina  32 asean  9 ATS  15 australia  109 austria  5 ayahuasca  6 bahamas  4 ballot 2012  155 banking  52 barbados  11 belgium  46 belize  10 bermuda  15 bhang  15 bolivia  118 brazil  95 brownfield doctrine  24 burma  45 california  216 cambodia  12 canada  543 cannabinoids  107 cannabis  3255 cannabis clubs  230 cannabis industry  417 caribbean  148 caricom  33 cbd oil  1 central america  5 chile  21 china  46 civil society  37 CND  131 coca  220 cocaine  95 coffee shop  230 cognitive decline  30 colombia  160 colorado  163 compulsary detention  19 conflict  4 conventions  277 corporate capture  59 corruption  5 costa rica  10 crack  55 craft cannabis  31 crime  92 czech republic  54 dark net  4 death penalty  3 decertification  1 decriminalization  935 deforestation  11 denmark  132 drug checking  41 drug consumption rooms  193 drug courts  22 drug markets  147 drug policy index  2 drug testing  7 drug trade  60 e-cigarettes  1 e-joint  2 ecstasy  70 ecuador  22 egypt  16 el salvador  2 environment  38 eradication  129 essential medicines  25 estonia  2 eswatini  7 ethiopia  3 european drug policy  119 expert advisory group  9 extrajudicial killings  95 fair trade  16 fentanyl  84 france  119 fumigation  27 gateway theory  29 georgia  3 germany  217 ghana  18 global commission  46 greece  19 guatemala  32 guatemala initiative  47 harm reduction  348 hemp  44 heroin  139 heroin assisted treatment  80 HIV/AIDS  61 home cultivation  124 honduras  4 human rights  259 ICC  1 illinois  10 incarceration  53 INCB  143 india  102 indigenous rights  1 indonesia  35 informal drug policy dialogues  22 inter se modification  17 iran  14 ireland  16 israel  63 italy  42 jamaica  176 japan  3 kava  4 kazakhstan  5 kenya  11 ketamine  27 khat  37 kratom  33 kyrgyzstan  1 laos  2 latin american debate  115 law enforcement  432 lebanon  43 legal highs  64 legalization  1709 lesotho  10 local customization  11 luxembourg  60 malawi  4 malaysia  7 malta  58 medical cannabis  665 mental health  45 methamphetamine  49 mexico  211 Mid-Term Review  1 mild stimulants  46 money laundering  55 morocco  128 naloxone  16 nepal  7 netherlands  341 new york  34 new zealand  67 NIDA  5 nigeria  1 nitrous oxide  9 norway  18 NPS  10 opinion polls  132 opioids  153 opium  94 oregon  29 overdose kits  4 pakistan  9 panama  5 paraguay  4 pardon  2 patents  18 peace  24 peru  45 peyote  3 philippines  89 pilot project  137 pleasure  5 poland  2 police pacification  18 portugal  68 potency  2 precursors  7 prevention  3 prison situation  101 prohibition  158 proportionality  110 psychedelics  13 psychosis  57 puerto rico  3 racism  29 reclassification  119 recriminalisation  42 regulation  1454 russia  36 sacramental use  11 safe supply  36 safer crack  29 scheduling  29 scientific research  145 sdg  2 security  14 senegal  1 sentencing  67 singapore  7 social justice  83 somalia  7 south africa  83 spain  81 st lucia  9 st vincent and grenadines  31 substance-use disorder  20 substitution treatment  31 sweden  31 switzerland  162 synthetic cannabinoids  31 taxation  58 teen use  43 thailand  78 thresholds  64 tobacco industry  17 traditional growers  162 tramadol  17 treatment  29 trinidad & tobago  15 tunisia  14 UK  282 UN Common Position  1 UN drug control  444 UNGASS  58 UNODC  111 uruguay  146 US drug policy  1192 vaping  2 venezuela  5 vietnam  5 violence  134 WHO  66 world drug report  11 yemen  6

This website

UN Drug Control

In 2011 the 1961 UN Single Convention on drugs will be in place for 50 years. In 2012 the international drug control system will exist 100 years since the International Opium Convention was signed in 1912 in The Hague. Does it still serve its purpose or is a reform of the UN Drug Conventions needed? This site provides critical background.

Drug Law Reform on the map

dlronthemap_und

Copyright © 2024 Drug Law Reform in Latin America

Website by WebWolf